Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03155425. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection
ClinicalTrials.gov study NCT00006436. IPD Sharing: YES. Countries: 1. Publications: 2.
Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT02227199. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy
ClinicalTrials.gov study NCT00381940. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00054665. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma
ClinicalTrials.gov study NCT00846742. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01055496. IPD Sharing: NO. Countries: 9. Publications: 2.
Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00312845. IPD Sharing: Not stated. Countries: 32. Publications: 2.
Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT01685008. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL
ClinicalTrials.gov study NCT02362997. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00225212. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03331341. IPD Sharing: NO. Countries: 1. Publications: 1.
Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas
ClinicalTrials.gov study NCT00069238. IPD Sharing: NO. Countries: 1. Publications: 4.
Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00742027. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab
ClinicalTrials.gov study NCT02747043. IPD Sharing: YES. Countries: 20. Publications: 1.
Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02339922. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00479167. IPD Sharing: Not stated. Countries: 1. Publications: 27.
Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00684411. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)
ClinicalTrials.gov study NCT02658968. IPD Sharing: NO. Countries: 5. Publications: 2.
Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00299494. IPD Sharing: Not stated. Countries: 13. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.